BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7095898)

  • 21. [Experimental teratocarcinoma in mice: a model system for the study of the relationship between cellular surface antigens and embryonic differentiation].
    Gachelin G
    Bull Cancer; 1976; 63(1):95-110. PubMed ID: 62594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine embryonal carcinoma cells express class I MHC-like antigens.
    Stern PL; Beresford N; Bell SM; Thompson S; Jones K; Mellor A
    J Immunogenet; 1986; 13(2-3):133-40. PubMed ID: 3546507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT.
    Damjanov I; Horvat B; Gibas Z
    Lab Invest; 1993 Feb; 68(2):220-32. PubMed ID: 7680083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of F9 antigens to spermatogenic cell antigens.
    Vojtísková M; Dráber P; Pokorná Z
    Cell Differ; 1984 Dec; 15(2-4):185-8. PubMed ID: 6152580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human teratocarcinomas.
    Andrews PW
    Biochim Biophys Acta; 1988 Aug; 948(1):17-36. PubMed ID: 3293662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro.
    Andrews PW
    Dev Biol; 1984 Jun; 103(2):285-93. PubMed ID: 6144603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of human testicular embryonal carcinoma and teratocarcinoma grown in nude mice and soft-agar cultures.
    Walt H; Hedinger CE
    Cell Differ; 1984 Dec; 15(2-4):81-6. PubMed ID: 6535649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies against surface antigens common to spermatogenic and F9 teratocarcinoma cells in mice immunized with blood group substances from human saliva.
    Dráber P; Pokorná Z; Vojtísková M
    Exp Clin Immunogenet; 1985; 2(3):174-82. PubMed ID: 3917147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmentally regulated surface structures of teratocarcinoma stem cells studied by mutant cell lines.
    Dráber P; Vojtísková M
    Cell Differ; 1984 Dec; 15(2-4):249-53. PubMed ID: 6535647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human teratocarcinoma stem cells: glycolipid antigen expression and modulation during differentiation.
    Andrews PW
    J Cell Biochem; 1987 Dec; 35(4):321-32. PubMed ID: 3326883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a human ovarian teratocarcinoma-derived cell line.
    Zeuthen J; Nørgaard JO; Avner P; Fellous M; Wartiovaara J; Vaheri A; Rosén A; Giovanella BC
    Int J Cancer; 1980 Jan; 25(1):19-32. PubMed ID: 6931103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human embryonal carcinoma cells and their differentiation in culture.
    Andrews PW; Fenderson B; Hakomori S
    Int J Androl; 1987 Feb; 10(1):95-104. PubMed ID: 2438234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours.
    Andrews PW; Casper J; Damjanov I; Duggan-Keen M; Giwercman A; Hata J; von Keitz A; Looijenga LH; Millán JL; Oosterhuis JW; Pera M; Sawada M; Schmoll HJ; Skakkebaek NE; van Putten W; Stern P
    Int J Cancer; 1996 Jun; 66(6):806-16. PubMed ID: 8647654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of the circulating antibodies to teratocarcinomadefined antigens in patients with testicular tumours.
    Teodorczyk-Injeyan J; Jewett MA; Burke CA; Ostrand-Rosenberg S
    Clin Exp Immunol; 1980 Jun; 40(3):438-44. PubMed ID: 6998614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neural rosette formation within in vitro spheroids of a clonal human teratocarcinoma cell line, PA-1/NR: role of extracellular matrix components in the morphogenesis.
    Kawata M; Sekiya S; Kera K; Kimura H; Takamizawa H
    Cancer Res; 1991 May; 51(10):2655-69. PubMed ID: 2021944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cis-platinum on embryonal carcinoma cell lines in vitro.
    Oosterhuis JW; Andrews PW; Knowles BB; Damjanov I
    Int J Cancer; 1984 Jul; 34(1):133-9. PubMed ID: 6540246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Embryonal carcinoma antigens: biologic and clinical implications.
    Artzt K
    Semin Oncol; 1979 Mar; 6(1):53-4. PubMed ID: 451631
    [No Abstract]   [Full Text] [Related]  

  • 38. H-2 class I antigen expression on mouse teratocarcinoma cell lines.
    Démant P; Oudshoorn-Snoek M
    Immunogenetics; 1985; 22(6):543-52. PubMed ID: 4077148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A human embryonal-yolk sac carcinoma model system in athymic mice.
    Vogelzang NJ; Bronson D; Savino D; Vessella RL; Fraley EF
    Cancer; 1985 Jun; 55(11):2584-93. PubMed ID: 2581684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variant embryonal carcinoma cells lacking SSEA-1 and Forsmann antigens remain developmentally pluripotent.
    Buckalew JJ; Sterman B; Rosenstraus M
    Dev Biol; 1985 Jan; 107(1):134-41. PubMed ID: 2856907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.